
51 - 200 employees
Founded 2016
🏥 Healthcare
💼 Consulting
⚖️ Legal
Healthcare • Consulting • Legal
Immunic Therapeutics is a late-stage biotechnology company focused on developing novel, orally administered small-molecule therapies for chronic inflammatory and autoimmune diseases, with particular programs targeting multiple sclerosis and celiac disease. The company advances differentiated clinical-stage programs (e. g. , vidofludimus calcium, IMU-856, IMU-381) aiming to provide efficacious, safe, and well-tolerated oral treatment options for neurologic and gastrointestinal immune-mediated conditions, while pursuing regulatory protections and commercialization pathways.
🕒 October 29
Where this job comes from
Posted on Immunic Therapeutics's careers page ↗, not through a job board
First seen by Remote Rocketship October 29
Still open on Immunic Therapeutics's site. Checked 35 minutes ago.

51 - 200 employees
Founded 2016
🏥 Healthcare
💼 Consulting
⚖️ Legal
Healthcare • Consulting • Legal
Immunic Therapeutics is a late-stage biotechnology company focused on developing novel, orally administered small-molecule therapies for chronic inflammatory and autoimmune diseases, with particular programs targeting multiple sclerosis and celiac disease. The company advances differentiated clinical-stage programs (e. g. , vidofludimus calcium, IMU-856, IMU-381) aiming to provide efficacious, safe, and well-tolerated oral treatment options for neurologic and gastrointestinal immune-mediated conditions, while pursuing regulatory protections and commercialization pathways.
• Establish and lead Immunic's HEOR capability within Medical Affairs • Develop and maintain a prioritized, multi-year HEOR and value-evidence strategy for vidofludimus calcium • Lead evidence-gap assessments and translate gaps into research questions, study concepts, investment recommendations, and decision points • Partner on Immunic's real-world evidence strategy, including MS registry engagement, commercial real-world data sources, and data-use agreements • Prioritize RWE research questions and represent HEOR in registry consortia and real-world data networks • Design and oversee HEOR and outcomes research, including burden-of-illness, epidemiology, treatment-pattern, patient-reported outcomes/quality-of-life, and economic-modeling studies • Develop budget-impact and cost-effectiveness models for payer, reimbursement, and HTA discussions • Integrate HEOR priorities into evidence-generation and publication strategies • Ensure studies and analyses are rigorous, documented, balanced, and transparent about assumptions, limitations, and uncertainty • Partner with clinical, biostatistics, regulatory, medical affairs, and other teams on outcomes, endpoints, patient-reported measures, and evidence-generation opportunities • Provide payer, HTA, patient, and healthcare-system perspectives during protocol development, analysis planning, and data interpretation • Partner with Market Access on payer and HTA evidence needs, value dossiers, evidence summaries, and related models • Represent HEOR in cross-functional program and launch-readiness forums • Build relationships with external HEOR experts, academic collaborators, research networks, payers, HTA experts, and MS-focused thought leaders • Translate external insights into HEOR hypotheses and research priorities • Communicate complex economic and outcomes concepts to audiences with varying technical expertise • Establish HEOR governance, planning, and decision-making processes • Select and direct external research partners while maintaining internal ownership of strategy, quality, and deliverables • Develop and manage the HEOR budget and resourcing model • Establish measures of progress and impact for the HEOR function
• At least eight years of progressive HEOR, outcomes research, RWE, or related evidence-generation experience in the biopharmaceutical industry, or six years with a PhD, PharmD, or MD • Experience developing or leading an integrated HEOR/value-evidence strategy • Experience supporting late-stage development, launch readiness, or lifecycle evidence generation • Advanced degree in health economics, outcomes research, epidemiology, health services research, public health, pharmacy, medicine, or a related quantitative or clinical discipline preferred • Strong knowledge of HEOR research methods • Hands-on experience designing, critically evaluating, or overseeing economic models and evidence-generation studies • Familiarity with registry-, claims-, or EHR-based real-world evidence research • Working knowledge of the US payer landscape • Familiarity with global HTA evidence requirements • Experience directing external research partners and managing scope, budget, timelines, scientific quality, and deliverables • Strong written and verbal communication skills • Comfort operating in a smaller, pre-commercial biotech environment with shifting priorities • Demonstrated ability to influence cross-functional stakeholders and drive decisions without formal authority • Must be authorized to work in the US
• Equity • Bonus • Remote work arrangement
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 October 29
Associate Director leading fire protection and plumbing engineering at DLB Associates, a mission-critical infrastructure engineering firm. Driving strategy, client programs, business development, and technology-enabled operational improvement.
🕒 October 29
Associate Director leading Revance’s Field Medical Advisor team and National Account partnerships. Supporting science-driven aesthetics, skincare, and therapeutics through compliant medical strategy and education.
🇺🇸 United States – Remote
💵 $225k - $250k / year
💰 $100M Post-IPO Equity - Revance Therapeutics on 2024-03
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Director
🕒 October 29
Senior Director leading Comfrt’s international ecommerce logistics, fulfillment, compliance, and market expansion. Managing global partners and teams to drive profitable growth beyond the US.
🕒 October 29
Senior Director leading analytical development, regulatory support, and commercialization for Mineralys Therapeutics’ hypertension medicines. Overseeing small-molecule CMC strategy, external laboratories, and analytical lifecycle management.
🇺🇸 United States – Remote
💵 $215k - $240k / year
🔥 Funding within the last year
💰 $500M Post-IPO Debt on 2026-06
⏰ Full Time
🔴 Lead
👔 Director
🕒 October 29
Illumina director leading global market access for oncology genomic diagnostics. Shaping reimbursement, evidence, payer engagement, and commercialization strategies worldwide.
🇺🇸 United States – Remote
💵 $205.1k - $307.7k / year
💰 $750M Post-IPO Debt on 2023-01
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor